title: Pseudotumor cerebri as a reversible side effect of all-trans retinoic acid treatment in acute promyelocytic leukaemia.
authors.forename: B
authors.initials: B
authors.lastname: Machner
authors.forename: B
authors.initials: B
authors.lastname: Neppert
authors.forename: M
authors.initials: M
authors.lastname: Paulsen
authors.forename: C
authors.initials: C
authors.lastname: Hofmann
authors.forename: T
authors.initials: T
authors.lastname: Sander
authors.forename: C
authors.initials: C
authors.lastname: Helmchen
mesh_terms: D000086:Acetazolamide / Q000627:therapeutic use; D000328:Adult; D000927:Anticonvulsants / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000009:adverse effects*; D005260:Female; D006801:Humans; D015255:Idarubicin / Q000627:therapeutic use; D015473:Leukemia, Promyelocytic, Acute / Q000188:drug therapy*; D009765:Obesity; D011559:Pseudotumor Cerebri / Q000139:chemically induced* / Q000628:therapy; D013129:Spinal Puncture; D014212:Tretinoin / Q000009:adverse effects*
chemical_list: D000927:Anticonvulsants; D000970:Antineoplastic Agents; D014212:Tretinoin; D000086:Acetazolamide; D015255:Idarubicin